ロード中...

Combinations of the First and Next Generations of Human Immunodeficiency Virus (HIV) Fusion Inhibitors Exhibit a Highly Potent Synergistic Effect against Enfuvirtide- Sensitive and -Resistant HIV Type 1 Strains

T20 (generic name, enfuvirtide; brand name, Fuzeon) is a first-generation human immunodeficiency virus (HIV) fusion inhibitor approved for salvage therapy of HIV-infected patients refractory to current antiretroviral drugs. However, its clinical use is limited because of rapid emergence of T20-resis...

詳細記述

保存先:
書誌詳細
主要な著者: Pan, Chungen, Cai, Lifeng, Lu, Hong, Qi, Zhi, Jiang, Shibo
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology (ASM) 2009
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2715752/
https://ncbi.nlm.nih.gov/pubmed/19493996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00168-09
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!